Thoracoabdominal Aortic Aneurysms

Not yet recruiting

• Conditions: Thoracoabdominal Aortic Aneurysm

• Registration Number: NCT06267573
• Lead Sponsor: Assiut University

Brief Summary

Evaluation of the effectiveness of the different modalities for treatment of thoracoabdominal aortic aneurysms. FEVAR and BEVAR devices are widely used now due to its feasability and wide range of use . We aim to evaluate the effectiveness of these new devices in the management of TAAA

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-02
• Study First Submitted: 2024-02-12
• Study First Submitted QC: 2024-02-19
• Last Update Submitted: 2024-02-19
• Study First Posted: 2024-02-20
• Last Update Posted: 2024-02-20
• Study Start: 2024-09
• Primary Completion: 2025-09-15
• Study Completion: 2026-09-10

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• all adult consecutive patients presenting with TAAA larger than 5.5 cm

Exclusion Criteria

• active infection Asymptomatic patients with small aneurysms Allergy to contrast agents

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Successful cannulation of the target vessels with complete in-line flow to target organs.	Two years	No ischemia